Etidronic Acid
-
Subject Areas on Research
- Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.
- Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
- Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
- European women's preference for osteoporosis treatment: influence of clinical effectiveness and dosing frequency.
- Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
- Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
- Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice.
- Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate.
- Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
- Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.